Company Listing
Cytos

Cytos was developing a therapeutic for allergic asthma. Following disappointing clinical results, Cytos merged in an all-stock transaction with the privately-held tissue repair and regeneration company, Kuros Biosurgery, in January 2016.

BACK
Location
Zurich, Switzerland

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Cytos was developing a therapeutic for allergic asthma. Following disappointing clinical results, Cytos merged in an all-stock transaction with the privately-held tissue repair and regeneration company, Kuros Biosurgery, in January 2016.

Location
Zurich, Switzerland
BACK
 
Copyright Abingworth 2017